Literature DB >> 27938504

Knockdown of miR-23, miR-27, and miR-24 Alters Fetal Liver Development and Blocks Fibrosis in Mice.

Charles E Rogler, Joe S Matarlo, Brian Kosmyna, Daniel Fulop, Leslie E Rogler.   

Abstract

MicroRNAs (miRNAs) regulate cell fate selection and cellular differentiation. miRNAs of the miR23b polycistron (miR-23b, miR-27b, and miR-24) target components of the TGF-β signaling pathway and affect murine bile ductular and hepatocyte cell fate selection in vitro. Here we show that miR-23b polycistron miRNAs directly target murine Smad4, which is required for TGF-β signaling. Injection of antagomirs against these miRNAs directly into E16.5 murine fetuses caused increased cytokeratin expression in sinusoids and primitive ductular elements throughout the parenchyma of newborn mice. Similar antagomir injection in newborn mice increased bile ductular differentiation in the liver periphery and reduced hepatocyte proliferation. Antagomir injection in newborn Alb/TGF-β1 transgenic mice that develop fibrosis inhibited the development of fibrosis, and injection of older mice caused the resolution of existing fibrosis. Furthermore, murine stellate cell activation, including ColA1 and ACTA2 expression, is regulated by miR-23b cluster miRNAs. In summary, knockdown of miR-23b cluster miRNAs in fetal and newborn liver promotes bile duct differentiation and can block or revert TGF-β-induced liver fibrosis that is dependent on stellate cell activation. These data may find practical application in the highly needed development of therapies for the treatment of fibrosis.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27938504      PMCID: PMC8751183          DOI: 10.3727/105221616X693891

Source DB:  PubMed          Journal:  Gene Expr        ISSN: 1052-2166


  54 in total

Review 1.  Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury.

Authors:  S L Friedman
Journal:  J Biol Chem       Date:  2000-01-28       Impact factor: 5.157

2.  Biochemical characteristics of isolated rat liver stellate cells.

Authors:  M Yamada; W S Blaner; D R Soprano; J L Dixon; H M Kjeldbye; D S Goodman
Journal:  Hepatology       Date:  1987 Nov-Dec       Impact factor: 17.425

3.  A skin microRNA promotes differentiation by repressing 'stemness'.

Authors:  Rui Yi; Matthew N Poy; Markus Stoffel; Elaine Fuchs
Journal:  Nature       Date:  2008-03-02       Impact factor: 49.962

Review 4.  Mechanisms of hepatic fibrogenesis.

Authors:  Scott L Friedman
Journal:  Gastroenterology       Date:  2008-05       Impact factor: 22.682

Review 5.  Smads: transcriptional activators of TGF-beta responses.

Authors:  R Derynck; Y Zhang; X H Feng
Journal:  Cell       Date:  1998-12-11       Impact factor: 41.582

6.  Hepatic stellate cell is activated by microRNA-181b via PTEN/Akt pathway.

Authors:  Jianjian Zheng; Cunzao Wu; Ziqiang Xu; Peng Xia; Peihong Dong; Bicheng Chen; Fujun Yu
Journal:  Mol Cell Biochem       Date:  2014-08-23       Impact factor: 3.396

Review 7.  The role of Ito cells in the biosynthesis of HGF-SF in the liver.

Authors:  P Schirmacher; A Geerts; W Jung; A Pietrangelo; C E Rogler; H P Dienes
Journal:  EXS       Date:  1993

8.  Hepatic expression of mature transforming growth factor beta 1 in transgenic mice results in multiple tissue lesions.

Authors:  N Sanderson; V Factor; P Nagy; J Kopp; P Kondaiah; L Wakefield; A B Roberts; M B Sporn; S S Thorgeirsson
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-28       Impact factor: 11.205

9.  The autoregulatory feedback loop of microRNA-21/programmed cell death protein 4/activation protein-1 (MiR-21/PDCD4/AP-1) as a driving force for hepatic fibrosis development.

Authors:  Zhengping Zhang; Yinhe Zha; Wei Hu; Zhen Huang; Zhongfei Gao; Yuhui Zang; Jiangning Chen; Lei Dong; Junfeng Zhang
Journal:  J Biol Chem       Date:  2013-11-06       Impact factor: 5.157

Review 10.  Hepatic Stellate Cells and microRNAs in Pathogenesis of Liver Fibrosis.

Authors:  Mio Kitano; P Mark Bloomston
Journal:  J Clin Med       Date:  2016-03-16       Impact factor: 4.241

View more
  6 in total

1.  Transmission of microRNA antimiRs to mouse offspring via the maternal-placental-fetal unit.

Authors:  Jonas Hönig; Ivana Mižíková; Claudio Nardiello; David E Surate Solaligue; Maximilian J Daume; István Vadász; Konstantin Mayer; Susanne Herold; Stefan Günther; Werner Seeger; Rory E Morty
Journal:  RNA       Date:  2018-03-14       Impact factor: 4.942

Review 2.  Regulatory long non-coding RNAs of hepatic stellate cells in liver fibrosis (Review).

Authors:  Zhengjie Wu; Shunmei Huang; Xiaoqin Zheng; Silan Gu; Qiaomai Xu; Yiwen Gong; Jiaying Zhang; Bin Fu; Lingling Tang
Journal:  Exp Ther Med       Date:  2021-02-11       Impact factor: 2.447

Review 3.  Roles of exosomes and exosome-derived miRNAs in pulmonary fibrosis.

Authors:  Yongfeng Yang; Hong Huang; Yi Li
Journal:  Front Pharmacol       Date:  2022-08-11       Impact factor: 5.988

Review 4.  Sphingosine 1-Phosphate Signaling as a Target in Hepatic Fibrosis Therapy.

Authors:  Bárbara González-Fernández; Diana I Sánchez; Javier González-Gallego; María J Tuñón
Journal:  Front Pharmacol       Date:  2017-08-25       Impact factor: 5.810

5.  The Lhx1-Ldb1 complex interacts with Furry to regulate microRNA expression during pronephric kidney development.

Authors:  Eugenel B Espiritu; Amanda E Crunk; Abha Bais; Daniel Hochbaum; Ailen S Cervino; Yu Leng Phua; Michael B Butterworth; Toshiyasu Goto; Jacqueline Ho; Neil A Hukriede; M Cecilia Cirio
Journal:  Sci Rep       Date:  2018-10-30       Impact factor: 4.379

Review 6.  The Roles and Mechanisms of lncRNAs in Liver Fibrosis.

Authors:  Zhi He; Deying Yang; Xiaolan Fan; Mingwang Zhang; Yan Li; Xiaobin Gu; Mingyao Yang
Journal:  Int J Mol Sci       Date:  2020-02-21       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.